Therapeuticsmd, Inc. share price logo

Therapeuticsmd, Inc. Share Price

NASDAQ: TXMD

Small Cap

$2.33

+0.07

(+3.10%)

as on

Therapeuticsmd, Inc. Stock Performance

as on February 4, 2026 at 2:29 am IST

  • Day's Low

    Day's High

    $2.21
    $2.42
    downward going graph

    5.15%

    Downside

    3.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.72
    $2.95
    downward going graph

    69.10%

    Downside

    26.61%

    Upside

    downward going graph

Therapeuticsmd, Inc. share price movements today

Previous Close
$2.26
Open
$2.42
Volume
273.4K
Day's Low - High
$2.21 - $2.42
52 Week Low - High
$0.72 - $2.95

Therapeuticsmd, Inc. Historical Returns

1 Month Return
+ 41.21 %
3 Month Return
+ 99.15 %
1 Year Return
+ 135.35 %
3 Year Return
-55.19 %
5 Year Return
-97.43 %

Therapeuticsmd, Inc. Stock Fundamentals & Key Indicators

Check Therapeuticsmd, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.1M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

277

Industry PE ratio

-1.9307053941908714

PEG Ratio

-0.73

EBITDA

-1.3M

Revenue (TTM)

2.8M

Profit Margin

10.80%

Return On Equity TTM

0.27%

Therapeuticsmd, Inc. Stock Valuation

Track how Therapeuticsmd, Inc. P/E has moved over time to understand its valuation trends.

Therapeuticsmd, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-9.62x)

March 31, 2025

Industry (-1.93x)

February 4, 2026

Today (277.00x)

February 4, 2026

Highest (29.55x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 277.00x

Therapeuticsmd, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Therapeuticsmd, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Therapeuticsmd, Inc. image
Therapeuticsmd, Inc.
SELL$32.1M-97.43%27710.80%
Regencell Bioscience Holdings Ltd image
Regencell Bioscience Holdings Ltd
NA$14.4BNANA0.00%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$21.6BNA18.0840.65%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$46.2BNA22.5413.81%
Viatris Inc. image
Viatris Inc.
HOLD$15.2B-24%-21.95-26.13%
See all

Stock Returns calculator for Therapeuticsmd, Inc. Stock including INR - Dollar returns

The Therapeuticsmd, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Therapeuticsmd, Inc. investment value today

Current value as on today

₹2,39,090

Returns

₹1,39,090

(+139.09%)

Returns from Therapeuticsmd, Inc. Stock

₹1,35,354 (+135.35%)

Dollar Returns*

₹3,737 (+3.74%)

Analyst Recommendation on Therapeuticsmd, Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Therapeuticsmd, Inc.. Average target price of $5

Therapeuticsmd, Inc. Share Price Target

Get share price movements and forecasts by analysts on Therapeuticsmd, Inc..

What analysts predicted

53.4%UPSIDE

Target Price

$5

Current Price

$2.33

Analyzed by

6 Analysts

Target

$5.00

Therapeuticsmd, Inc. target price $5, a slight upside of 53.4% compared to current price of $2.33. According to 6 analysts rating.

Therapeuticsmd, Inc. Stock’s Investor Sentiment and Interest

Search interest for Therapeuticsmd, Inc. Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Therapeuticsmd, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-1
-1
-1
-2
0
0
0
0
0
EBITDA
-2
-1
0
-1
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
-
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-1
-1
0
-1
0
0
0
0
0
Income Tax Expense
0
2
0
0
0
0
0
0
0
0
Net Income
-2
-3
0
0
-1
0
0
0
0
0
Net Profit Margin
-552.40%
6373.58%
-175.90%
-234.50%
-465.81%
-111.33%
37.78%
-166.16%
57.88%
19.39%

Therapeuticsmd, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
20
19
16
16
49
64
2
69
1
1
Gross Profit
15
15
14
13
43
48
1
68
1
1
Operating Income
-85
-90
-77
-130
-151
-155
-79
1
-8
-4
EBITDA
-85
-89
-76
-127
-158
-153
-70
11
-8
-2
Interest Expense
-
-
-
4
17
28
32
12
-
0
Depreciation
-
-
0
0
1
4
4
1
0
0
Income Before Tax
-85
-89
-76
-132
-176
-183
-79
1
-7
-2
Income Tax Expense
0
0
0
2
19
29
33
-91
0
0
Net Income
-85
-89
-76
-132
-176
-183
-172
111
-10
-2
Net Profit Margin
-422.37%
-464.32%
-458.50%
-823.74%
-354.79%
-282.90%
-6700.93%
160.08%
-789.40%
-123.85%

Therapeuticsmd, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-1
-1
0
-1
0
0
0
0
0
Operating Cash Flow
-2
-7
0
0
0
0
0
0
1
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-1
2
2
-
-
-
-
-
-
Change in Cash
-3
-5
0
0
0
0
0
0
1

Therapeuticsmd, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-89
-76
-132
-176
-183
-79
1
-7
-2
Operating Cash Flow
-69
-76
-106
-165
-159
-147
-4
-48
0
Investing Cash Flow
-1
0
-21
-23
-1
-2
223
-
-
Financing Cash Flow
137
72
162
188
80
134
-235
3
-
Change in Cash
66
-4
34
0
-80
-15
-15
-44
0

Global Institutional Holdings in Therapeuticsmd, Inc.

Funds
Holdings
Clearline Capital LP
5.49%
J. Goldman & Co LP
0.12%
Bridgeway Capital Management, LLC
0.29%
State Street Corp
0.26%
Northern Trust Corp
0.14%
See all

Insights on Therapeuticsmd, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TXMD stock has moved up by 8.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regencell Bioscience Holdings Ltd has given 26995.2% return, outperforming this stock by 26859.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Regencell Bioscience Holdings Ltd has given 3552.6% return, outperforming this stock by 3607.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 551.0K → 152.0K (in $), with an average decrease of 72.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 952.0K → 784.0K (in $), with an average decrease of 17.7% per quarter

About Therapeuticsmd, Inc.

"TherapeuticsMD Inc. is an inventive pharmaceutical company that focuses exclusively on healthcare products for women and informs on women’s health problems. The company is dedicated to producing advanced therapeutic products related to family planning, reproductive health, and menopause management with the view to addressing the unique challenges that women face in the different phases of their lives. Founded in 2008 by Brian Bernick and Robert Finizio, the company is headquartered in Boca Raton, Florida. TherapeuticsMD delivers bio-identical hormones in various forms and administration methods using its homegrown SYMBODA technology. It makes fetal vitamins and other nutritional supplements under its vitaMedMD brand and exclusively prescribed prenatal vitamins through BocaGreenMD. These products are produced by a third-party manufacturer- Lang Pharma Nutrition. The company's solutions include long-lasting contraceptives, pharmaceutical products for hormone therapy, and patient-controlled contraceptives. Aside from developing prescription-only hormone therapy products for women, TherapeuticsMD is designing products to address menopausal vasomotor symptoms and dyspareunia. Currently, the firm markets and sells its products through a direct national sales force of about 50 full-time professionals that target health care providers in the OB/GYN sector. Medical professionals may also be able to provide patients with an alternative that meets their individual nutritional and financial needs about co-pays and costs of care and saves them money compared with competing products.. Currently Therapeuticsmd, Inc. has a market cap of $0.03 Billion. It has a P.E ratio of 277.00. The shares of Therapeuticsmd, Inc. are trading at {current share price in dollars (in INR)}."
OrganisationTherapeuticsmd, Inc.
Headquarters951 Yamato Road, Boca Raton, FL, United States, 33431
IndustryHealth Technology
CEOMr. Marlan D. Walker J.D.
E-voting on sharesClick here to vote

Key Management of Therapeuticsmd, Inc.

Name

Title

Mr. Marlan D. Walker J.D.

Chief Executive Officer

Mr. Joseph A. Ziegler

Principal Financial & Accounting Officer

Mr. Douglas Steelman

Vice President of Market Access

FAQs

What is Therapeuticsmd, Inc. share price today?

Therapeuticsmd, Inc. share price today is $2.33 as on at the close of the market. Therapeuticsmd, Inc. share today touched a day high of $2.42 and a low of $2.21.

What is the 52 week high and 52 week low for Therapeuticsmd, Inc. share?

Therapeuticsmd, Inc. share touched a 52 week high of $2.95 on and a 52 week low of $0.72 on . Therapeuticsmd, Inc. stock price today i.e. is closed at $2.33,which is 21.02% down from its 52 week high and 223.61% up from its 52 week low.

What is Therapeuticsmd, Inc.'s market capitalisation today?

Therapeuticsmd, Inc. market capitalisation is $0.00T as on .

How to invest in Therapeuticsmd, Inc. Stock (TXMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Therapeuticsmd, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Therapeuticsmd, Inc. Shares that will get you 0.6438 shares as per Therapeuticsmd, Inc. share price of $2.33 per share as on February 4, 2026 at 2:29 am IST.

What is the minimum amount required to buy Therapeuticsmd, Inc. Stock (TXMD) from India?

Indian investors can start investing in Therapeuticsmd, Inc. (TXMD) shares with as little as ₹90.22 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.20 in Therapeuticsmd, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Therapeuticsmd, Inc. share’s latest price of $2.33 as on February 4, 2026 at 2:29 am IST, you will get 4.2918 shares of Therapeuticsmd, Inc.. Learn more about fractional shares .

What are the returns that Therapeuticsmd, Inc. has given to Indian investors in the last 5 years?

Therapeuticsmd, Inc. stock has given -97.43% share price returns and 25.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?